PMID- 35135919 OWN - NLM STAT- MEDLINE DCOM- 20220908 LR - 20221006 IS - 1349-7235 (Electronic) IS - 0918-2918 (Print) IS - 0918-2918 (Linking) VI - 61 IP - 17 DP - 2022 Sep 1 TI - The First Case of Gastric Neuroendocrine Tumors Induced by a Proton Pump Inhibitor in von Hippel-Lindau Disease. PG - 2587-2592 LID - 10.2169/internalmedicine.8701-21 [doi] AB - Von Hippel-Lindau (VHL) disease is a rare inherited familial syndrome complicated with various neoplasms, including neuroendocrine tumors (NETs). We herein report the first case of multiple gastric NETs in a 45-year-old man with VHL. He had multiple gastric polyps, and several endoscopic resected lesions were diagnosed as NETs. The serum gastrin level was elevated because he was taking a proton pump inhibitor (PPI). We suspected that gastrin had played a role in the development of NETs, and the remaining polyps were followed up with discontinuation of the PPI. The NETs gradually reduced in size until they became hard to notice on endoscopy and have remained nearly invisible for over eight years. FAU - Kawaguchi, Koichiro AU - Kawaguchi K AD - Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Japan. FAU - Yashima, Kazuo AU - Yashima K AD - Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Japan. FAU - Ikebuchi, Yuichiro AU - Ikebuchi Y AD - Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Japan. FAU - Yoshida, Akira AU - Yoshida A AD - Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Japan. FAU - Kuwamoto, Satoshi AU - Kuwamoto S AD - Department of Pathology, Faculty of Medicine, Tottori University, Japan. FAU - Isomoto, Hajime AU - Isomoto H AD - Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Japan. LA - eng PT - Case Reports PT - Journal Article DEP - 20220208 PL - Japan TA - Intern Med JT - Internal medicine (Tokyo, Japan) JID - 9204241 RN - 0 (Gastrins) RN - 0 (Proton Pump Inhibitors) SB - IM MH - Gastrins MH - Humans MH - Male MH - Middle Aged MH - *Neuroendocrine Tumors/complications/diagnosis/drug therapy MH - Proton Pump Inhibitors/adverse effects MH - *Stomach Neoplasms/complications/drug therapy MH - *von Hippel-Lindau Disease/complications PMC - PMC9492478 OTO - NOTNLM OT - gastrin OT - neuroendocrine tumor (NET) OT - proton pump inhibitor (PPI) OT - von Hippel-Lindau disease (VHL) COIS- The authors state that they have no Conflict of Interest (COI). EDAT- 2022/02/10 06:00 MHDA- 2022/09/09 06:00 PMCR- 2022/09/01 CRDT- 2022/02/09 05:42 PHST- 2022/02/10 06:00 [pubmed] PHST- 2022/09/09 06:00 [medline] PHST- 2022/02/09 05:42 [entrez] PHST- 2022/09/01 00:00 [pmc-release] AID - 10.2169/internalmedicine.8701-21 [doi] PST - ppublish SO - Intern Med. 2022 Sep 1;61(17):2587-2592. doi: 10.2169/internalmedicine.8701-21. Epub 2022 Feb 8.